|
EP0477454A1
(en)
|
1990-09-28 |
1992-04-01 |
Merrell Dow Pharmaceuticals Inc. |
Novel phosphonate derivatives of certain nucleosides
|
|
WO2002048165A2
(en)
|
2000-12-15 |
2002-06-20 |
Pharmasset Ltd. |
Antiviral agents for treatment of flaviviridae infections
|
|
US20040229839A1
(en)
|
2003-05-14 |
2004-11-18 |
Biocryst Pharmaceuticals, Inc. |
Substituted nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases
|
|
WO2005020885A2
(en)
|
2003-05-21 |
2005-03-10 |
Isis Pharmaceuticals, Inc. |
Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
|
|
WO2007139946A2
(en)
|
2006-05-25 |
2007-12-06 |
University Of Tennessee Research Foundation |
Gpcr ligands identified by computational modeling
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
|
US20090274686A1
(en)
|
2008-05-02 |
2009-11-05 |
Yat Sun Or |
Nucleoside phosphonate derivatives
|
|
WO2015164573A1
(en)
*
|
2014-04-25 |
2015-10-29 |
Vitae Pharmaceuticals, Inc. |
Purine derivatives as cd73 inhibitors for the treatment of cancer
|
|
CN104530166B
(zh)
|
2014-12-04 |
2016-08-24 |
陕西汉江药业集团股份有限公司 |
选择性还原4,6-共轭双烯-3-酮甾体化合物的方法
|
|
EA036379B1
(ru)
|
2014-12-12 |
2020-11-02 |
Блубёрд Био, Инк. |
Химерные антигенные рецепторы к bcma
|
|
WO2017098421A1
(en)
|
2015-12-08 |
2017-06-15 |
Glaxosmithkline Intellectual Property Development Limited |
Benzothiadiazine compounds
|
|
HUE063388T2
(hu)
|
2016-01-08 |
2024-01-28 |
Arcus Biosciences Inc |
Ekto-5'-nukleotidáz modulátorok és ezek alkalmazása
|
|
TWI767937B
(zh)
|
2016-09-09 |
2022-06-21 |
美商卡利泰拉生物科技公司 |
外核苷酸酶抑制劑及其使用方法
|
|
CN110049767B
(zh)
*
|
2016-10-03 |
2023-04-04 |
艾库斯生物科学有限公司 |
腺苷5′-核苷酸酶的抑制剂
|
|
EP3541396A4
(en)
|
2016-11-18 |
2020-07-22 |
Arcus Biosciences, Inc. |
CD73-MEDIATED IMMUNOSUPPRESSION INHIBITORS
|
|
JP7138351B2
(ja)
|
2016-12-22 |
2022-09-16 |
キャリセラ バイオサイエンシーズ， インコーポレイテッド |
エクトヌクレオチダーゼ阻害剤およびその使用方法
|
|
US20200115404A1
(en)
*
|
2017-03-31 |
2020-04-16 |
Peloton Therapeutics, Inc. |
Cd73 inhibitors and uses thereof
|
|
WO2018208727A1
(en)
|
2017-05-08 |
2018-11-15 |
Eternity Bioscience Inc. |
Nucleoside and nucleotide analogues as cd73 inhibitors and therapeutic uses thereof
|
|
WO2018208980A1
(en)
|
2017-05-10 |
2018-11-15 |
Oric Pharmaceuticals, Inc. |
Cd73 inhibitors
|
|
US11377469B2
(en)
|
2017-11-03 |
2022-07-05 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
WO2019129059A1
(zh)
|
2017-12-29 |
2019-07-04 |
上海和誉生物医药科技有限公司 |
一种具有cd73抑制活性的膦酸衍生物、其制备方法和应用
|
|
CN112423764A
(zh)
|
2018-04-30 |
2021-02-26 |
欧瑞克制药公司 |
Cd73抑制剂
|
|
EP3810109B1
(en)
*
|
2018-05-31 |
2024-08-07 |
Peloton Therapeutics, Inc. |
Compounds and compositions for inhibiting cd73
|
|
AU2019288495B2
(en)
|
2018-06-21 |
2024-02-08 |
Antengene Therapeutics Limited |
Ectonucleotidase inhibitors and methods of use thereof
|
|
EP3843714B1
(en)
|
2018-08-27 |
2025-11-12 |
Arcus Biosciences, Inc. |
Cd73 inhibitors
|
|
KR20220024629A
(ko)
|
2019-06-20 |
2022-03-03 |
칼리테라 바이오사이언시즈, 인코포레이티드 |
엑토뉴클레오티다제 억제제 및 이의 사용 방법
|
|
US12544391B2
(en)
|
2019-07-16 |
2026-02-10 |
Oric Pharmaceuticals, Inc. |
CD73 inhibitors
|
|
HUE072504T2
(hu)
|
2019-10-30 |
2025-11-28 |
Oric Pharmaceuticals Inc |
CD73-inhibitorok
|